PubMed COVID-19 Clinical Care
2501 - 2510 of 4555 results found
SARS-CoV-2 main protease mutation analysis via a kinematic method
Description
The Severe Acute Respiratory Syndrome CoronaVirus 2 (SARS-CoV-2) is the virus responsible for the COVID-19 pandemic. COVID-19 continues to cause millions of deaths globally in part due to immune-evading mutations. SARS-CoV-2 main protease (Mpro) is
Senolytics combat COVID-19 in aging
Description
No abstract
SARS-CoV-2-specific T cell responses wane profoundly in convalescent individuals 10 months after primary infection
Description
A key question in the coronavirus disease 2019 (COVID-19) pandemic is the duration of specific T cell responses against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) post primiry infection, which is difficult to address due to the
Studies probe COVID-19 shots' link to rare symptoms
Description
Details emerge for uncommon cases of neurologic complications, blood pressure swings, and other side effects.
Spot(ters) the difference: Bringing traditional anatomical examinations online
Description
The COVID-19 pandemic caused a shift in anatomy education forcing institutions to find innovative ways to teach and assess online. This study details the development of an online spotter across multiple modules that allowed students to sit the
Student Nurses as Workforce Extenders: A Pandemic-Proof Education Innovation
Description
CONCLUSION: The partnership was safe and feasible, allowing students to meet the clinical objectives without additional burden to staff nurses. [J Nurs Educ. 2023;62(7):416-419.].
SARS-CoV-2-specific immune responses and clinical outcomes after COVID-19 vaccination in patients with immune-suppressive disease
Description
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) immune responses and infection outcomes were evaluated in 2,686 patients with varying immune-suppressive disease states after administration of two Coronavirus Disease 2019 (COVID-19)
Status of New Vaccine Introduction - Worldwide, 2016-2021
Description
This report describes the status of introductions globally for eight World Health Organization (WHO)-recommended new and underutilized vaccines, comprising 10 individual vaccine antigens. By 2021, among 194 countries worldwide, 33 (17%) provided all
SARS-CoV-2 ORF7a protein blocks virus clearance by regulating autophagy
Description
No abstract
